Definitions — Narcotic Drug, Psychotropic Substance, Manufactured Drug, Commercial Quantity (Section 2)

Almost every contested NDPS prosecution turns, in the end, on a definition. Was the seized powder a narcotic drug or a psychotropic substance — and does that distinction change the punishment? Was the tablet a manufactured drug at all, or a lawful medicinal preparation? And, most consequentially, did the seizure cross the commercial quantity threshold that triggers the rigorous minimum sentence of ten years and the reverse burden under Sections 35 and 54? Section 2 of the Narcotic Drugs and Psychotropic Substances Act, 1985 supplies the answers, and the Supreme Court has spent four decades refining them. This chapter unpacks each definition clause-by-clause, traces the seismic shift from E. Micheal Raj to Hira Singh on how mixtures are weighed, and shows why a candidate who confuses these categories in an answer script effectively concedes the case.

Why the definitions in Section 2 decide the case

The NDPS Act is a punishment statute calibrated almost entirely by definition. The substantive offences in Sections 15 to 23 do not describe conduct in the ordinary sense; they describe handling a defined substance in a defined quantity. Whether an accused faces rigorous imprisonment of up to one year, up to ten years, or ten to twenty years depends not on what he did but on which Section 2 box the seized material falls into. A definitional misclassification therefore is not a technicality — it is the difference between bail and a decade in prison.

Section 2 opens with the standard “unless the context otherwise requires” formula and then defines over thirty terms. Four carry the heaviest litigation load: narcotic drug (clause xiv), psychotropic substance (clause xxiii), manufactured drug (clause xi) and the quantity thresholds — commercial quantity (clause viia) and small quantity (clause xxiiia). These are the gateways to the offence and punishment provisions you will study in offences and penalties. To see how Section 2 fits the larger architecture of control, regulation and enforcement, read it alongside the introduction, object and scheme chapter and the NDPS Act hub.

“Narcotic drug” — Section 2(xiv)

Section 2(xiv) defines narcotic drug to mean coca leaf, cannabis (hemp), opium, poppy straw and includes all manufactured drugs. The definition is deliberately closed in its base — only the four named natural products — but opened up through the residuary inclusion of “all manufactured drugs.” This drafting choice matters: a substance is a narcotic drug under the Act only if it is one of the four naturally occurring items or has been brought within the manufactured-drug definition. The Act does not treat “narcotic” as a loose pharmacological label; it is a statutory term of art.

Each of the four limbs is itself defined elsewhere in Section 2. Coca leaf and coca derivative, cannabis (hemp) in clause (iii) (covering charas, ganja and any mixture or drink prepared from them, but notably excluding the seeds and leaves of the cannabis plant when not accompanied by the tops), the cannabis plant in clause (iv) as any plant of the genus cannabis, opium in clause (xv), opium derivative in clause (xvi) (which includes morphine, codeine and diacetylmorphine, i.e. heroin) and poppy straw in clause (xviii) as all parts of the opium poppy after harvesting except the seeds. The structure means heroin is a narcotic drug not because the word “heroin” appears in clause (xiv) but because it is an opium derivative and an opium derivative is a manufactured drug.

The botanical definition of cannabis has had real consequences. Because clause (iii) covers charas and ganja — the resin and the flowering or fruiting tops — but excludes the seeds and leaves when not accompanied by the tops, the prosecution must prove that what was seized falls within the defined forms. Mere possession of cannabis leaves without the tops can fall outside the definition of “cannabis (hemp)” altogether, a point repeatedly pressed in trial courts.

“Psychotropic substance” — Section 2(xxiii)

Section 2(xxiii) defines a psychotropic substance as any substance, natural or synthetic, or any natural material or any salt or preparation of such substance or material included in the list of psychotropic substances specified in the Schedule to the Act. Unlike the narcotic-drug definition, which is anchored to four named plants, the psychotropic-substance definition is entirely Schedule-driven. If the substance — or its salt or preparation — is listed in the Schedule, it is psychotropic; if it is not listed, it is not, however potent it may be pharmacologically.

This Schedule-dependence is the single most important practical feature of the definition. The Schedule lists substances such as amphetamine, methaqualone, diazepam and alprazolam by their international names. A defence that the seized salt is not the exact listed form, or that it is a preparation not covered, is a recurring line of attack, and the prosecution must establish the link between the seized material and a Schedule entry through proper chemical analysis.

An important question is the relationship between the NDPS Act and the Drugs and Cosmetics Act, 1940 for psychotropic medicines. In Union of India v. Sanjeev V. Deshpande, (2014) 13 SCC 1, the Supreme Court held that the mere fact that a psychotropic substance is also a “drug” capable of being licensed and dealt with under the Drugs and Cosmetics regime does not take it outside the NDPS Act; dealing with such a substance otherwise than in accordance with the NDPS Act and the rules made under it remains an offence. The two statutes operate in addition to, and not in derogation of, each other. The Court has reaffirmed this complementary reading in later decisions, rejecting the argument that licensing under the Drugs and Cosmetics framework immunises an accused from NDPS liability.

Narcotic drug versus psychotropic substance — why the line matters

Candidates frequently treat “narcotic” and “psychotropic” as interchangeable. They are not, and the Act keeps them rigorously distinct for two reasons. First, the source of definition differs: narcotic drugs flow from the four named natural products plus manufactured drugs, while psychotropic substances flow entirely from the Schedule. Second, and more practically, the offence and punishment sections are split along this line. Offences relating to manufactured drugs and preparations sit in Section 21; offences relating to psychotropic substances sit in Section 22; cannabis in Section 20; opium in Sections 17 to 19; coca in Section 16. A charge under the wrong section can vitiate a conviction.

The common thread is that both categories use the same quantity machinery. Whether a substance is narcotic or psychotropic, the punishment graduates by small, intermediate (lesser-than-commercial) and commercial quantity. So while classification fixes which offence section applies, the quantity definitions fix how severe the punishment is within that section. For the granular quantity tables and their interpretation, see the dedicated chapter on small, intermediate and commercial quantity.

“Manufactured drug” — Section 2(xi)

Section 2(xi) defines manufactured drug to mean (a) all coca derivatives, medicinal cannabis, opium derivatives and poppy straw concentrate; and (b) any other narcotic substance or preparation which the Central Government may, having regard to the available information and the international conventions, by notification declare to be a manufactured drug. The definition expressly excludes any narcotic substance or preparation which the Central Government may, by notification, declare not to be a manufactured drug.

The clause therefore has a fixed core (the four enumerated derivative classes) and a flexible periphery (substances the Central Government may add or remove by notification). This delegated power lets the executive keep pace with new synthetic drugs and with India's obligations under the Single Convention on Narcotic Drugs, 1961, without amending the parent Act each time. The practical lesson for the exam is that “manufactured drug” is not a free-standing scientific category; its outer boundary is drawn by Central Government notifications.

The interplay between the manufactured-drug definition and the rules has produced litigation. In State of Uttarakhand v. Rajesh Kumar Gupta, (2007) 1 SCC 355, the Supreme Court examined whether dealing in a psychotropic substance not specifically listed in Schedule I to the NDPS Rules attracted the prohibition under those rules, and approached the question through the definitions and the statutory scheme. More recently, the Court has clarified that the mere mention of a substance in the schedule to the NDPS Act suffices to attract the Act even where the substance is also regulated under other regimes, reinforcing that the definitions in Section 2 — not the rules alone — control coverage.

“Commercial quantity” and “small quantity” — Sections 2(viia) and 2(xxiiia)

The 2001 amendment introduced a graded sentencing structure pegged to quantity, and Section 2 supplies the two definitions that anchor it. Section 2(viia) defines commercial quantity, in relation to narcotic drugs and psychotropic substances, as any quantity greater than the quantity specified by the Central Government by notification in the Official Gazette. Section 2(xxiiia) defines small quantity as any quantity lesser than the quantity specified by the Central Government by notification. The band between the two — quantity that is more than small but less than commercial — is the unnamed “intermediate” or “less than commercial” quantity that attracts the middle tier of punishment.

Both definitions are deliberately empty shells filled by executive notification. The operative notification is S.O. 1055(E) dated 19 October 2001, which tabulates, for each listed drug, the figures for small and commercial quantity. For heroin, for instance, the small quantity is 5 grams and the commercial quantity is 250 grams; for the corresponding figures across all listed substances, the table in the notification is the authoritative source.

Why the definitions matter so much: crossing the commercial-quantity line triggers the rigorous punishment of ten to twenty years under the relevant offence section, makes bail extraordinarily difficult through the twin conditions of Section 37, and engages the presumptions of culpable mental state (Section 35) and the reverse burden under Section 54. A few grams either side of the threshold can therefore reshape the entire trial. These thresholds connect directly to the control and licensing framework discussed in prohibition, control and regulation.

Weighing mixtures: the rule in E. Micheal Raj

The quantity definitions sound simple until the seized material is not pure drug but a mixture of drug and inert filler — as it almost always is in street-level heroin. Does one weigh only the actual narcotic content, or the entire mixture including the neutral substance? The answer determines whether 4 grams of heroin cut into 300 grams of powder is a small quantity or a commercial quantity.

In E. Micheal Raj v. Intelligence Officer, Narcotic Control Bureau, (2008) 5 SCC 161, a two-judge bench held that in a mixture of a narcotic drug with one or more neutral substances, the quantity of the neutral substance is not to be taken into account; only the actual content by weight of the offending narcotic drug is relevant for determining whether the seizure is a small or commercial quantity. The Court reasoned that the legislative intent behind the graded scheme was to punish those trafficking in large quantities of the actual drug, not those caught with a small quantity of drug diluted in a large volume of harmless material. For over a decade this “actual content” rule governed sentencing across the country.

The shift to entire-mixture weighing: Hira Singh v. Union of India

In the meantime, the Central Government had attempted to displace the E. Micheal Raj approach administratively. By Notification S.O. 2942(E) dated 18 November 2009 it added Note 4 to the 2001 quantity notification, stipulating that the quantity shown in the table applies to the entire mixture or any solution or any one or more narcotic drugs or psychotropic substances of that particular drug in dosage form or isolated drug — in other words, the whole mixture is to be weighed, not just the pure content.

The validity of Note 4 came before a three-judge bench in Hira Singh v. Union of India, (2020) 20 SCC 272, decided on 22 April 2020. The Court overruled E. Micheal Raj and held that in determining whether a seizure is a small or commercial quantity, the weight of the neutral substance in the mixture must be taken into account along with the weight of the offending drug. The entire weight of the mixture or solution is to be considered. The Court upheld Note 4 as intra vires the scheme of the Act, reasoning that the statutory definitions in Section 2(viia) and 2(xxiiia) speak of “any quantity” of the narcotic drug or psychotropic substance and that, once a substance is mixed, the mixture as a whole answers that description.

The doctrinal consequence is significant. After Hira Singh, a small amount of pure heroin diluted in a large quantity of neutral powder can be a commercial quantity, exposing the accused to ten to twenty years and the rigours of Section 37 bail. Candidates must state clearly that Hira Singh is now the governing authority and that E. Micheal Raj stands overruled; an answer that still treats E. Micheal Raj as good law on mixture-weighing is simply wrong. The continuing academic and judicial criticism of Hira Singh — that it punishes beyond culpability — may be noted, but it remains the law unless and until a larger bench reconsiders it.

Note 4 in detail: isolated drug versus dosage form

Note 4 to the 2001 notification, as upheld in Hira Singh, distinguishes between an isolated drug and a drug in dosage form or as part of a mixture or solution. For an isolated drug, the actual quantity is the relevant weight. For a drug in dosage form or in a mixture or solution, the entire weight of the dosage units, mixture or solution is taken. This is why, post-Hira Singh, the form in which the contraband is seized — loose powder, cut mixture, tablets, or liquid solution — directly affects the quantity computation and thus the punishment tier.

For psychotropic medicines in tablet form, the Court's approach in Sanjeev V. Deshpande and the entire-mixture logic of Hira Singh together mean that the gross weight of the seized tablets, rather than only the net salt content, is generally the relevant measure for the quantity threshold. This makes proper sampling, weighment and chemical analysis by the prosecution central to a sustainable conviction, and a frequent battleground in cross-examination.

How the definitions interlock with the punishment scheme

It helps to see the four definitions as a decision tree the trial court runs for every seizure. First, classification: is the substance a narcotic drug under Section 2(xiv) or a psychotropic substance under Section 2(xxiii)? That answer routes the case to the correct offence section (16 to 23). Within that section, the second question is quantity: applying Section 2(viia) and 2(xxiiia) and the 2001 notification as read in Hira Singh, is the seizure small, intermediate, or commercial? That answer fixes the punishment band, the availability of bail under Section 37, and the operation of the presumptions under Sections 35 and 54.

The third, often-decisive question is procedural compliance — was the search and seizure lawful? Although that belongs to a different part of the Act, it is worth flagging here because the most rigorous safeguards apply precisely where the quantity is commercial. In State of Punjab v. Baldev Singh, (1999) 6 SCC 172, a Constitution Bench held that compliance with the Section 50 safeguard — informing the suspect of the right to be searched before a gazetted officer or magistrate — is mandatory for personal searches, and that contraband recovered in breach cannot be used to convict. The definitions decide what was seized; provisions such as Section 50 decide whether the seizure can be proved at all.

Drafting points and common pitfalls

Several recurring errors cost marks and cases. First, conflating “narcotic drug” and “psychotropic substance” — remember the former is a closed list of four naturals plus manufactured drugs, the latter is purely Schedule-driven. Second, treating “manufactured drug” as a scientific category rather than a notification-bounded one. Third, and most damaging in 2026, citing E. Micheal Raj as authority for actual-content weighing without flagging that Hira Singh has overruled it on this point.

Fourth, candidates sometimes forget that the quantity definitions are empty without the 2001 notification — the figures are not in the Act. Fifth, the “intermediate” quantity has no statutory name; it is simply the band between small and commercial and attracts the middle punishment tier. Knowing the consequences of crossing the commercial line — minimum ten years, Section 37 twin conditions for bail, reverse burden — is what separates a competent answer from a superficial one. These consequences echo through the chapters on offences and penalties and on punishment for repeat offences.

A note on accuracy and sources

The bare definitions reproduced above track Section 2 of the NDPS Act, 1985 as published on the official India Code portal and the corresponding text on Indian Kanoon. The quantity figures derive from Notification S.O. 1055(E) dated 19 October 2001 and its Note 4 inserted by S.O. 2942(E) dated 18 November 2009. The case law has been cross-checked: Hira Singh v. Union of India, (2020) 20 SCC 272 (three-judge bench, decided 22 April 2020) overrules E. Micheal Raj v. Intelligence Officer, NCB, (2008) 5 SCC 161 on the weighing of mixtures; Union of India v. Sanjeev V. Deshpande, (2014) 13 SCC 1 governs the NDPS–Drugs and Cosmetics overlap for psychotropic substances; and State of Punjab v. Baldev Singh, (1999) 6 SCC 172 is the Constitution Bench authority on Section 50. Where a precise SCC paragraph or notification serial is needed for an answer, candidates should consult the primary text rather than relying on a paraphrase.